The Brief Analysis of Peptide-combined Nanoparticle: Nanomedicine’s Unique Value

Author(s): Jiemin Wang, Junyong Wu, Yongjiang Li, Jing Wen, Jiaxin Cai, Tiantian Tang, Xiongbin Hu, Daxiong Xiang*.

Journal Name: Current Protein & Peptide Science

Volume 21 , Issue 4 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Therapeutic peptides (TPs) are biological macromolecules which can act as neurotransmitters, hormones, ion channel ligands and growth factors. Undoubtedly, TPs are crucial in modern medicine. But low bio-stability and some special adverse reactions reduce their places to the application.

With the development of nanotechnology, nanoparticles (NPs) in pharmaceutical science gained much attention. They can encapsulate the TPs into their membrane or shell. Therefore, they can protect the TPs against degradation and then increase the bioavailability, which was thought to be the biggest advantage of them. Additionally, targeting was also studied to improve the effect of TPs. However, there were some drawbacks of nano TPs like low loading efficiency and difficulty to manufacture.

Nowadays, lots of studies focused on improving effect of TPs by preparing nanoparticles. In this review, we presented a brief analysis of peptide-combined nanoparticles. Their advantages and disadvantages were listed in terms of mechanism. And several examples of applications were summarized.

Keywords: Therapeutic peptides, nanoparticle, ligands, active targeting, passive targeting, encapsulation, drug delivery.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 4
Year: 2020
Page: [334 - 343]
Pages: 10
DOI: 10.2174/1389203721666200210103841
Price: $65

Article Metrics

PDF: 11